Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

Biotechnology: Crossing the barrier

Researchers have rallied round a promising molecule for rescuing dying nerves. But getting it into the brain remains a daunting challenge, finds Brian Vastag.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout


  1. Airaksinen, M. S. & Saarma, M. Nature Rev. Neurosci. 3, 383-394 (2002).

    Article  CAS  Google Scholar 

  2. Gill, S. S. et al. Nature Med. 9, 589-595 (2003).

    Article  CAS  Google Scholar 

  3. Love, S. et al. Nature Med. 11, 703-704 (2005).

    Article  CAS  Google Scholar 

  4. Pardridge, W. M., Kang, Y. S., Buciak, J. L. & Yang, J. Pharm. Res. 12, 807-816 (1995).

    Article  CAS  Google Scholar 

  5. Pardridge, W. M. & Boado, R. J. Pharm. Res. 26, 2227-2236 (2009).

    Article  CAS  Google Scholar 

Download references


Additional information

Brian Vastag is a freelance reporter in Washington DC.

Related links

Related links

Related links in Nature Research

Related external links

ArmaGen Technologies


MedGenesis Therapeutix

Amgen announces end of GDNF testing

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vastag, B. Biotechnology: Crossing the barrier. Nature 466, 916–918 (2010).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research